ResMed will report the September quarter result in October 30. Ord Minnett expects solid ventilator sales and a speedy recovery in sleep laboratories sales, particularly in the US.

Ord Minnett retains its Lighten recommendation and raises the target to $21 from $20.

Sector: Health Care Equipment & Services.

Target price is $21.00.Current Price is $25.77. Difference: ($4.77) - (brackets indicate current price is over target). If RMD meets the Ord Minnett target it will return approximately -23% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2020 Acquisdata Pty Ltd., source FN Arena